A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Commentary: Pill to terminate early pregnancies unlikely to become available without a prescription for years, if ever, experts say; the pill, mifepristone, combined with second drug misoprostol, is only available through a certified doctor's prescription

Analysts on Enanta suing Pfizer over Covid pill Paxlovid: SVB Securities says it's unclear whether Enanta is in the right, noting patent dates might not prove who 'invented' technology first; RBC says it could take years for lawsuit to reach conclusion

Enanta files suit in US District Court against Pfizer seeking damages for copyright infringement related to Paxlovid nirmatrelvir, ritonavir tablets; Enanta applied for a patent for a coronavirus protease inhibitor in 2020 and received patent this month

AbbVie submits supplemental new drug application to FDA for Atogepant Qulipt, a preventive treatment for chronic migraines in adults; migraines affect 39 million people in US, are highest cause of disability for those under 50 years of age

Launch prices for new drugs increased 20% per year from 2008 to 2021, growing from median price of US$2,115 per year in 2008 to US$180,007 per year in 2021; drug launch prices outpacing prices for other healthcare services: study

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count